{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["CADM1", "Hepatocellular carcinoma", "Liver cancer stem cell", "LncRNA DLX6-AS1", "STAT3 signaling pathway"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31171015", "DateCompleted": {"Year": "2019", "Month": "11", "Day": "25"}, "DateRevised": {"Year": "2022", "Month": "05", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "06", "Day": "06"}], "Language": ["eng"], "ELocationID": ["237", "10.1186/s13046-019-1239-3"], "Journal": {"ISSN": "1756-9966", "JournalIssue": {"Volume": "38", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Jun", "Day": "06"}}, "Title": "Journal of experimental & clinical cancer research : CR", "ISOAbbreviation": "J Exp Clin Cancer Res"}, "ArticleTitle": "Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.", "Pagination": {"StartPage": "237", "MedlinePgn": "237"}, "Abstract": {"AbstractText": ["Liver cancer stem cells (LCSCs) are a small subset of cells characterized by unlimited self-renewal, cell differentiation, and uncontrollable cellular growth. LCSCs are also resistant to conventional therapies and are thus believed to be held responsible for causing treatment failure of hepatocellular carcinoma (HCC). It has been recently found that long non-coding RNAs (lncRNAs) are important regulators in HCC. This present study aims to explore the underlying mechanism of how lncRNA DLX6-AS1 influences the development of LCSCs and HCC.", "A microarray-based analysis was performed to initially screen differentially expressed lncRNAs associated with HCC. We then analyzed the lncRNA DLX6-AS1 levels as well as CADM1 promoter methylation. The mRNA and protein expression of CADM1, STAT3, CD133, CD13, OCT-4, SOX2, and Nanog were then detected. We quantified our results by evaluating the spheroid formation, proliferation, and tumor formation abilities, as well as the proportion of tumor stem cells, and the recruitment of DNA methyltransferase (DNMT) in LCSCs when lncRNA DLX6-AS1 was either overexpressed or silenced.", "LncRNA DLX6-AS1 was upregulated in HCC. The silencing of lncRNA DLX6-AS1 was shown to reduce and inhibit spheroid formation, colony formation, proliferation, and tumor formation abilities, as well as attenuate CD133, CD13, OCT-4, SOX2, and Nanog expression in LCSCs. Furthermore, downregulation of lncRNA DLX6-AS1 contributed to a reduction in CADM1 promoter methylation via suppression of DNMT1, DNMT3a, and DNMT3b in LCSCs and inactivating the STAT3 signaling pathway.", "This study demonstrated that down-regulated lncRNA DLX6-AS1 may inhibit the stem cell properties of LCSCs through upregulation of CADM1 by suppressing the methylation of the CADM1 promoter and inactivation of the STAT3 signaling pathway."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116, Jiangsu Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, 221116, Jiangsu Province, People's Republic of China."}], "LastName": "Wu", "ForeName": "Dong-Mei", "Initials": "DM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory Cultivation Base For TCM Quality and Efficacy, School of Medicine and Life Sciences, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China."}], "LastName": "Zheng", "ForeName": "Zi-Hui", "Initials": "ZH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, Qiqihar Medical University, Qiqihar, 161006, People's Republic of China."}], "LastName": "Zhang", "ForeName": "Ying-Bo", "Initials": "YB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116, Jiangsu Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, 221116, Jiangsu Province, People's Republic of China."}], "LastName": "Fan", "ForeName": "Shao-Hua", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116, Jiangsu Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, 221116, Jiangsu Province, People's Republic of China."}], "LastName": "Zhang", "ForeName": "Zi-Feng", "Initials": "ZF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116, Jiangsu Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, 221116, Jiangsu Province, People's Republic of China."}], "LastName": "Wang", "ForeName": "Yong-Jian", "Initials": "YJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116, Jiangsu Province, People's Republic of China. ylzheng@jsnu.edu.cn."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, 221116, Jiangsu Province, People's Republic of China. ylzheng@jsnu.edu.cn."}], "LastName": "Zheng", "ForeName": "Yuan-Lin", "Initials": "YL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116, Jiangsu Province, People's Republic of China. lu-jun75@163.com."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, 221116, Jiangsu Province, People's Republic of China. lu-jun75@163.com."}], "LastName": "Lu", "ForeName": "Jun", "Initials": "J"}], "GrantList": [{"GrantID": "PAPD", "Agency": "the Priority Academic Program Development of Jiangsu Higher Education Institutions", "Country": ""}, {"GrantID": "0", "Agency": "the 2016 333 Project Award of Jiangsu Province", "Country": ""}, {"GrantID": "0", "Agency": "the 2013 Qinglan Project of the Young and Middle-aged Academic Leader of Jiangsu College and University", "Country": ""}, {"GrantID": "81571055, 81400902, 81271225, 31201039, 81171012, and 30950031", "Agency": "the National Natural Science Foundation of China", "Country": ""}, {"GrantID": "13KJA180001", "Agency": "the Major Fundamental Research Program of the Natural Science Foundation of the Jiangsu Higher Education Institutions of China", "Country": ""}, {"GrantID": "0", "Agency": "the Cultivate National Science Fund for Distinguished Young Scholars of Jiangsu Normal University", "Country": ""}], "PublicationTypeList": ["Journal Article", "Retracted Publication"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Exp Clin Cancer Res", "NlmUniqueID": "8308647", "ISSNLinking": "0392-9078"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers, Tumor"}, {"RegistryNumber": "0", "NameOfSubstance": "CADM1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Cell Adhesion Molecule-1"}, {"RegistryNumber": "0", "NameOfSubstance": "DLX6 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Homeodomain Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Long Noncoding"}, {"RegistryNumber": "0", "NameOfSubstance": "STAT3 Transcription Factor"}], "CommentsCorrectionsList": [{"RefSource": "J Exp Clin Cancer Res. 2022 Apr 1;41(1):121. doi: 10.1186/s13046-022-02347-9", "PMID": "35365213"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Biomarkers, Tumor"}, {"QualifierName": ["genetics"], "DescriptorName": "Cell Adhesion Molecule-1"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Cell Transformation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "DNA Methylation"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Gene Expression Profiling"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Gene Silencing"}, {"QualifierName": [], "DescriptorName": "Heterografts"}, {"QualifierName": ["genetics"], "DescriptorName": "Homeodomain Proteins"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics", "metabolism", "pathology"], "DescriptorName": "Liver Neoplasms"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Models, Biological"}, {"QualifierName": ["metabolism"], "DescriptorName": "Neoplastic Stem Cells"}, {"QualifierName": [], "DescriptorName": "Promoter Regions, Genetic"}, {"QualifierName": ["genetics"], "DescriptorName": "RNA, Long Noncoding"}, {"QualifierName": ["metabolism"], "DescriptorName": "STAT3 Transcription Factor"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Cheng S, Chen M, Cai J. National Research Cooperative Group for D, treatment of hepatocellular carcinoma with tumor T. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition. Oncotarget. 2017;8(5):8867\u20138876. doi: 10.18632/oncotarget.13958.", "ArticleIdList": ["10.18632/oncotarget.13958", "PMC5352449", "27780939"]}, {"Citation": "Yu L, Sun Y, Li J, Wang Y, Zhu Y, Shi Y, Fan X, Zhou J, Bao Y, Xiao J, et al. Silencing the Girdin gene enhances radio-sensitivity of hepatocellular carcinoma via suppression of glycolytic metabolism. J Exp Clin Cancer Res. 2017;36(1):110. doi: 10.1186/s13046-017-0580-7.", "ArticleIdList": ["10.1186/s13046-017-0580-7", "PMC5558715", "28810896"]}, {"Citation": "An J, Zhang Z, Liu Z, Wang R, Hui D, Jin Y. Overexpression of Cullin7 is associated with hepatocellular carcinoma progression and pathogenesis. BMC Cancer. 2017;17(1):828. doi: 10.1186/s12885-017-3839-7.", "ArticleIdList": ["10.1186/s12885-017-3839-7", "PMC5718086", "29207970"]}, {"Citation": "Chen J, Rajasekaran M, Hui KM. Atypical regulators of Wnt/beta-catenin signaling as potential therapeutic targets in hepatocellular carcinoma. Exp Biol Med (Maywood) 2017;242(11):1142\u20131149. doi: 10.1177/1535370217705865.", "ArticleIdList": ["10.1177/1535370217705865", "PMC5478001", "28429652"]}, {"Citation": "Yong KJ, Gao C, Lim JS, Yan B, Yang H, Dimitrov T, Kawasaki A, Ong CW, Wong KF, Lee S, et al. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med. 2013;368(24):2266\u20132276. doi: 10.1056/NEJMoa1300297.", "ArticleIdList": ["10.1056/NEJMoa1300297", "PMC3781214", "23758232"]}, {"Citation": "Cancer Genome Atlas Research Network. Electronic address wbe, Cancer Genome Atlas Research N Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell. 2017;169(7):1327\u20131341. doi: 10.1016/j.cell.2017.05.046.", "ArticleIdList": ["10.1016/j.cell.2017.05.046", "PMC5680778", "28622513"]}, {"Citation": "Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105\u2013111. doi: 10.1038/35102167.", "ArticleIdList": ["10.1038/35102167", "11689955"]}, {"Citation": "Xiao Y, Lin M, Jiang X, Ye J, Guo T, Shi Y, Bian X. The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy. Anal Cell Pathol (Amst) 2017;2017:5108653.", "ArticleIdList": ["PMC5551471", "28819584"]}, {"Citation": "Cai Z, Xu K, Li Y, Lv Y, Bao J, Qiao L. Long noncoding RNA in liver cancer stem cells. Discov Med. 2017;24(131):87\u201393.", "ArticleIdList": ["28972877"]}, {"Citation": "Yang J, Lin J, Liu T, Chen T, Pan S, Huang W, Li S. Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes. Lung Cancer. 2014;85(2):110\u2013115. doi: 10.1016/j.lungcan.2014.05.011.", "ArticleIdList": ["10.1016/j.lungcan.2014.05.011", "24906504"]}, {"Citation": "Wang P, Mokhtari R, Pedrosa E, Kirschenbaum M, Bayrak C, Zheng D, Lachman HM. CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells. Mol Autism. 2017;8:11. doi: 10.1186/s13229-017-0124-1.", "ArticleIdList": ["10.1186/s13229-017-0124-1", "PMC5357816", "28321286"]}, {"Citation": "Zhang L, He X, Jin T, Gang L, Jin Z. Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway. Biomed Pharmacother. 2017;96:884\u2013891. doi: 10.1016/j.biopha.2017.10.056.", "ArticleIdList": ["10.1016/j.biopha.2017.10.056", "29145165"]}, {"Citation": "Zhang RM, Tang T, Yu HM, Yao XD. LncRNA DLX6-AS1/miR-129-5p/DLK1 axis aggravates stemness of osteosarcoma through Wnt signaling. Biochem Biophys Res Commun. 2018;507(1\u20134):260\u2013266. doi: 10.1016/j.bbrc.2018.11.019.", "ArticleIdList": ["10.1016/j.bbrc.2018.11.019", "30442366"]}, {"Citation": "Komohara Y, Ma C, Yano H, Pan C, Horlad H, Saito Y, Ohnishi K, Fujiwara Y, Okuno Y, Nosaka K, et al. Cell adhesion molecule-1 (CADM1) expressed on adult T-cell leukemia/lymphoma cells is not involved in the interaction with macrophages. J Clin Exp Hematop. 2017;57(1):15\u201320. doi: 10.3960/jslrt.17003.", "ArticleIdList": ["10.3960/jslrt.17003", "PMC6144270", "28420814"]}, {"Citation": "Zhang W, Xie HY, Ding SM, Xing CY, Chen A, Lai MC, Zhou L, Zheng SS. CADM1 regulates the G1/S transition and represses tumorigenicity through the Rb-E2F pathway in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2016;15(3):289\u2013296. doi: 10.1016/S1499-3872(16)60099-1.", "ArticleIdList": ["10.1016/S1499-3872(16)60099-1", "27298105"]}, {"Citation": "Zhang W, Zhou L, Ding SM, Xie HY, Xu X, Wu J, Chen QX, Zhang F, Wei BJ, Eldin AT, et al. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation. Oncol Rep. 2011;25(4):1053\u20131062.", "ArticleIdList": ["21271221"]}, {"Citation": "Ching RHH, Sze KMF, Lau EYT, Chiu YT, Lee JMF, Ng IOL, Lee TKW. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway. Oncotarget. 2017;8(14):23507\u201323516. doi: 10.18632/oncotarget.15183.", "ArticleIdList": ["10.18632/oncotarget.15183", "PMC5410322", "28186991"]}, {"Citation": "Vallath S, Sage EK, Kolluri KK, Lourenco SN, Teixeira VS, Chimalapati S, George PJ, Janes SM, Giangreco A. CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity. Sci Rep. 2016;6:24006. doi: 10.1038/srep24006.", "ArticleIdList": ["10.1038/srep24006", "PMC4817512", "27035095"]}, {"Citation": "Lin Qing, Zheng Hongying, Xu Jianjun, Zhang Feng, Pan Huazheng. LncRNA SNHG16 aggravates tumorigenesis and development of hepatocellular carcinoma by sponging miR\u20104500 and targeting STAT3. Journal of Cellular Biochemistry. 2019;120(7):11604\u201311615. doi: 10.1002/jcb.28440.", "ArticleIdList": ["10.1002/jcb.28440", "30779219"]}, {"Citation": "Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u2013140. doi: 10.1093/bioinformatics/btp616.", "ArticleIdList": ["10.1093/bioinformatics/btp616", "PMC2796818", "19910308"]}, {"Citation": "Liu L, Liu C, Zhang Q, Shen J, Zhang H, Shan J, Duan G, Guo D, Chen X, Cheng J, et al. SIRT1-mediated transcriptional regulation of SOX2 is important for self-renewal of liver cancer stem cells. Hepatology. 2016;64(3):814\u2013827. doi: 10.1002/hep.28690.", "ArticleIdList": ["10.1002/hep.28690", "27312708"]}, {"Citation": "Liu XF, Thin KZ, Ming XL, Shuo L, Ping L, Man Z, Li ND, Tu JC. Small Nucleolar RNA Host Gene 18 Acts as a Tumor Suppressor and a Diagnostic Indicator in Hepatocellular Carcinoma. Technol Cancer Res Treat. 2018;17:1533033818794494.", "ArticleIdList": ["PMC6104208", "30126319"]}, {"Citation": "Hung MH, Tai WT, Shiau CW, Chen KF. Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapy. World J Gastroenterol. 2014;20(41):15269\u201315274. doi: 10.3748/wjg.v20.i41.15269.", "ArticleIdList": ["10.3748/wjg.v20.i41.15269", "PMC4223260", "25386075"]}, {"Citation": "Zheng ZK, Pang C, Yang Y, Duan Q, Zhang J, Liu WC. Serum long noncoding RNA urothelial carcinoma-associated 1: a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma. J Int Med Res. 2018;46(1):348\u2013356. doi: 10.1177/0300060517726441.", "ArticleIdList": ["10.1177/0300060517726441", "PMC6011314", "28856933"]}, {"Citation": "Zeng X, Hu Z, Ke X, Tang H, Wu B, Wei X, Liu Z. Long noncoding RNA DLX6-AS1 promotes renal cell carcinoma progression via miR-26a/PTEN axis. Cell Cycle. 2017;16(22):2212\u20132219. doi: 10.1080/15384101.2017.1361072.", "ArticleIdList": ["10.1080/15384101.2017.1361072", "PMC5736339", "28881158"]}, {"Citation": "Li J, Li P, Zhao W, Yang R, Chen S, Bai Y, Dun S, Chen X, Du Y, Wang Y, et al. Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma. Cancer Cell Int. 2015;15:48. doi: 10.1186/s12935-015-0201-5.", "ArticleIdList": ["10.1186/s12935-015-0201-5", "PMC4458341", "26052251"]}, {"Citation": "Sakurai-Yageta M, Maruyama T, Suzuki T, Ichikawa K, Murakami Y. Dynamic regulation of a cell adhesion protein complex including CADM1 by combinatorial analysis of FRAP with exponential curve-fitting. PLoS One. 2015;10(3):e0116637. doi: 10.1371/journal.pone.0116637.", "ArticleIdList": ["10.1371/journal.pone.0116637", "PMC4364555", "25780926"]}, {"Citation": "Wang YP, Lei QY. Metabolic recoding of epigenetics in cancer. Cancer Commun (Lond) 2018;38(1):25. doi: 10.1186/s40880-018-0302-3.", "ArticleIdList": ["10.1186/s40880-018-0302-3", "PMC5993135", "29784032"]}, {"Citation": "Reinert T, Modin C, Castano FM, Lamy P, Wojdacz TK, Hansen LL, Wiuf C, Borre M, Dyrskjot L, Orntoft TF. Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers. Clin Cancer Res. 2011;17(17):5582\u20135592. doi: 10.1158/1078-0432.CCR-10-2659.", "ArticleIdList": ["10.1158/1078-0432.CCR-10-2659", "21788354"]}, {"Citation": "Henken FE, Wilting SM, Overmeer RM, van Rietschoten JG, Nygren AO, Errami A, Schouten JP, Meijer CJ, Snijders PJ, Steenbergen RD. Sequential gene promoter methylation during HPV-induced cervical carcinogenesis. Br J Cancer. 2007;97(10):1457\u20131464. doi: 10.1038/sj.bjc.6604055.", "ArticleIdList": ["10.1038/sj.bjc.6604055", "PMC2360246", "17971771"]}, {"Citation": "van Kempen PM, van Bockel L, Braunius WW, Moelans CB, van Olst M, de Jong R, Stegeman I, van Diest PJ, Grolman W, Willems SM. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation. Cancer Med. 2014;3(5):1185\u20131196. doi: 10.1002/cam4.313.", "ArticleIdList": ["10.1002/cam4.313", "PMC4302669", "25065733"]}, {"Citation": "Fukuhara H, Kuramochi M, Fukami T, Kasahara K, Furuhata M, Nobukuni T, Maruyama T, Isogai K, Sekiya T, Shuin T, et al. Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer. Jpn J Cancer Res. 2002;93(6):605\u2013609. doi: 10.1111/j.1349-7006.2002.tb01297.x.", "ArticleIdList": ["10.1111/j.1349-7006.2002.tb01297.x", "PMC5927049", "12079507"]}, {"Citation": "Tai WT, Chu PY, Shiau CW, Chen YL, Li YS, Hung MH, Chen LJ, Chen PL, Su JC, Lin PY, et al. STAT3 mediates regorafenib-induced apoptosis in hepatocellular carcinoma. Clin Cancer Res. 2014;20(22):5768\u20135776. doi: 10.1158/1078-0432.CCR-14-0725.", "ArticleIdList": ["10.1158/1078-0432.CCR-14-0725", "25248379"]}, {"Citation": "Han Q, Wang Y, Pang M, Zhang J. STAT3-blocked whole-cell hepatoma vaccine induces cellular and humoral immune response against HCC. J Exp Clin Cancer Res. 2017;36(1):156. doi: 10.1186/s13046-017-0623-0.", "ArticleIdList": ["10.1186/s13046-017-0623-0", "PMC5688805", "29115974"]}, {"Citation": "Lin L, Amin R, Gallicano GI, Glasgow E, Jogunoori W, Jessup JM, Zasloff M, Marshall JL, Shetty K, Johnson L, et al. The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling. Oncogene. 2009;28(7):961\u2013972. doi: 10.1038/onc.2008.448.", "ArticleIdList": ["10.1038/onc.2008.448", "PMC2703464", "19137011"]}, {"Citation": "Liu Y, Choi DS, Sheng J, Ensor JE, Liang DH, Rodriguez-Aguayo C, Polley A, Benz S, Elemento O, Verma A, et al. HN1L promotes triple-negative breast Cancer stem cells through LEPR-STAT3 pathway. Stem Cell Reports. 2018;10(1):212\u2013227. doi: 10.1016/j.stemcr.2017.11.010.", "ArticleIdList": ["10.1016/j.stemcr.2017.11.010", "PMC5768915", "29249663"]}, {"Citation": "Sengupta S, Nagalingam A, Muniraj N, Bonner MY, Mistriotis P, Afthinos A, Kuppusamy P, Lanoue D, Cho S, Korangath P, et al. Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3. Oncogene. 2017;36(41):5709\u20135721. doi: 10.1038/onc.2017.164.", "ArticleIdList": ["10.1038/onc.2017.164", "PMC5793218", "28581518"]}, {"Citation": "Luo Y, Cui Y, Cao X, Li X, Chen A, Zhang J, Chen X, Cao J. 8-Bromo-7-methoxychrysin-blocked STAT3/twist axis inhibits the stemness of cancer stem cell-like cell originated from SMMC-7721 cells. Acta Biochim Biophys Sin Shanghai. 2017;49(5):458\u2013464. doi: 10.1093/abbs/gmx025.", "ArticleIdList": ["10.1093/abbs/gmx025", "28369327"]}, {"Citation": "Wang X, Sun W, Shen W, Xia M, Chen C, Xiang D, Ning B, Cui X, Li H, Li X, et al. Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis. J Hepatol. 2016;64(6):1283\u20131294. doi: 10.1016/j.jhep.2016.01.019.", "ArticleIdList": ["10.1016/j.jhep.2016.01.019", "26812074"]}, {"Citation": "Junk DJ, Bryson BL, Smigiel JM, Parameswaran N, Bartel CA, Jackson MW. Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling. Oncogene. 2017;36(28):4001\u20134013. doi: 10.1038/onc.2017.33.", "ArticleIdList": ["10.1038/onc.2017.33", "PMC5509502", "28288136"]}, {"Citation": "Jung JG, Shih IM, Park JT, Gerry E, Kim TH, Ayhan A, Handschuh K, Davidson B, Fader AN, Selleri L, et al. Ovarian Cancer Chemoresistance relies on the stem cell reprogramming factor PBX1. Cancer Res. 2016;76(21):6351\u20136361. doi: 10.1158/0008-5472.CAN-16-0980.", "ArticleIdList": ["10.1158/0008-5472.CAN-16-0980", "PMC7375390", "27590741"]}, {"Citation": "Thiagarajan PS, Zheng Q, Bhagrath M, Mulkearns-Hubert EE, Myers MG, Lathia JD, Reizes O. STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance. Endocr Relat Cancer. 2017;24(8):415\u2013426. doi: 10.1530/ERC-16-0349.", "ArticleIdList": ["10.1530/ERC-16-0349", "PMC5551450", "28729467"]}, {"Citation": "Yang C, Cai WC, Dong ZT, Guo JW, Zhao YJ, Sui CJ, Yang JM. lncARSR promotes liver cancer stem cells expansion via STAT3 pathway. Gene. 2019;687:73\u201381. doi: 10.1016/j.gene.2018.10.087.", "ArticleIdList": ["10.1016/j.gene.2018.10.087", "30391438"]}]}], "History": [{"Year": "2018", "Month": "12", "Day": "13"}, {"Year": "2019", "Month": "5", "Day": "21"}, {"Year": "2019", "Month": "6", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "6", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "6", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["31171015", "PMC6554918", "10.1186/s13046-019-1239-3", "10.1186/s13046-019-1239-3"]}}]}